Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
MRM Stock Forecast 2026-2027
$0.98
Current Price
$7.70M
Market Cap
Buy 1
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to MRM Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
MRM Price Momentum
-3.9%
1 Week Change
-16.9%
1 Month Change
-27.9%
1 Year Change
-49.5%
Year-to-Date Change
-78.1%
From 52W High of $4.45
+8.3%
From 52W Low of $0.90
📊 TOP ANALYST CALLS
Did MRM Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Medirom is one of their latest high-conviction picks.
Latest MRM Stock Price Targets & Analyst Predictions
MRM has shown a year-to-date change of -49.5% and a 1-year change of -27.9%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for MRM. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
MRM Analyst Ratings
1
Buy
0
Hold
0
Sell
MRM Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $0.98
Latest MRM Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for MRM.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Medirom Healthcare Technologies Inc. (MRM) Competitors
The following stocks are similar to Medirom based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Medirom Healthcare Technologies Inc. (MRM) Financial Data
Medirom Healthcare Technologies Inc. has a market capitalization of $7.70M with a P/E ratio of 2.7x. The company generates $49.88M in trailing twelve-month revenue with a 0.5% profit margin.
Revenue growth is -6.7% quarter-over-quarter, while maintaining an operating margin of -25.8% and return on equity of +53.2%.
Valuation Metrics
Market Cap
$7.70M
Enterprise Value
$25.65M
P/E Ratio
2.7x
PEG Ratio
N/A
Price/Sales
0.0x
Growth & Margins
Revenue Growth (YoY)
-6.7%
Gross Margin
N/A
Operating Margin
-25.8%
Net Margin
+0.5%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+424.0%
Current Ratio
0.2x
Debt/Equity
786.4x
ROE
+53.2%
ROA
-1.8%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Medirom Healthcare Technologies Inc. (MRM) Business Model
About Medirom Healthcare Technologies Inc.
What They Do
Provides healthcare services and digital health solutions.
Business Model
The company operates relaxation and bodywork salons under the Re.Ra.Ku brand, generating revenue through both company-owned and franchised locations. Additionally, it develops health-tech solutions that focus on preventive care and remote health monitoring, creating a dual revenue stream from wellness services and digital healthcare technologies.
Additional Information
Based in Tokyo, Japan, Medirom targets individuals seeking body care and organizations in need of modern health management tools. Its diversified approach positions it well within Japan's growing healthcare and wellness sectors.
Company Information
Sector
Consumer Cyclical
Industry
Personal Services
Employees
334
CEO
Mr. Kouji Eguchi
Country
Japan
IPO Year
N/A
Website
medirom.co.jpMedirom Healthcare Technologies Inc. (MRM) Latest News & Analysis
Latest News
MEDIROM MOTHER Labs Expands Deployment of "REMONY®" Remote Health Monitoring System in JGSDF 8th Division
18 days ago
Quick Summary
The "MOTHER Bracelet®" has received additional orders that triple its implementation scale, enhancing continuous safety monitoring during extended training sessions.
Why It Matters
The increase in orders for the "MOTHER Bracelet®" indicates growing market demand and potential revenue growth, signaling positive prospects for the company's financial performance.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Micromem Technologies Inc. (CSE: MRM, OTCQB: MMTIF) reported completion of its cost analysis and engineering review for a wearable unit prototype after meetings with the Department of National Defence.
Why It Matters
Micromem's progress with the Department of National Defence on a wearable unit prototype signals potential government contracts, which could enhance revenue and investor confidence.
Source: Newsfile Corp
Market Sentiment:
Neutral
Micromem Closes Private Placement
25 days ago
Quick Summary
Micromem Technologies Inc. closed a non-brokered private placement, raising C$235,000 by issuing 9.4 million units at C$0.025 each, with attached warrants exercisable at C$0.05 for two years.
Why It Matters
Micromem's private placement raises C$235,000, enhancing liquidity and funding potential projects. The issuance of warrants at C$0.05 may signal growth expectations, impacting stock valuations.
Source: Newsfile Corp
Market Sentiment:
Neutral
MEDIROM Group Reports Q1 2026 Results
1 month ago
Quick Summary
A report on Q1 2026 business performance and key metrics has been released, showing trends from Q1 2025 to Q1 2026, focusing on salons' financial and customer data.
Why It Matters
Q1 2026 performance insights and trends over five quarters allow investors to evaluate business growth, financial health, and customer engagement, crucial for informed decision-making.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
MEDIROM Healthcare Technologies Inc. announced the effective date of a Master Service Agreement with Tools for Humanity and World Foundation as of February 2, 2026.
Why It Matters
The agreement with Tools for Humanity and World Foundation may enhance Medirom’s growth prospects, indicating potential revenue streams and strategic partnerships, impacting investor sentiment positively.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
MEDIROM Healthcare Technologies Inc. has signed a Master Service Agreement with Tools for Humanity and the World Foundation to support World ID adoption by installing Orbs in 3,000 locations across Japan.
Why It Matters
MEDIROM's partnership with Tools for Humanity and the World Foundation to support World ID adoption signals potential growth and expansion opportunities, enhancing its market presence and revenue prospects.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About MRM Stock
What is Medirom Healthcare Technologies Inc.'s (MRM) stock forecast for 2027?
Analyst forecasts for Medirom Healthcare Technologies Inc. (MRM) are not currently available. The stock is trading at $0.98.
Is MRM stock a good investment in 2027?
According to current analyst ratings, MRM has 1 Buy ratings, 0 Hold ratings, and 0 Sell ratings. The stock is currently trading at $0.98. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for MRM stock?
Price predictions from Wall Street analysts for MRM are not currently available. The stock is trading at $0.98.
What is Medirom Healthcare Technologies Inc.'s business model?
The company operates relaxation and bodywork salons under the Re.Ra.Ku brand, generating revenue through both company-owned and franchised locations. Additionally, it develops health-tech solutions that focus on preventive care and remote health monitoring, creating a dual revenue stream from wellness services and digital healthcare technologies.
What is the highest forecasted price for MRM Medirom Healthcare Technologies Inc.?
Price targets from Wall Street analysts for MRM are not currently available. The stock is trading at $0.98.
What is the lowest forecasted price for MRM Medirom Healthcare Technologies Inc.?
Price targets from Wall Street analysts for MRM are not currently available. The stock is trading at $0.98.
What is the overall MRM consensus from analysts for Medirom Healthcare Technologies Inc.?
The overall analyst consensus for MRM is bullish. Out of 0 Wall Street analysts, 1 rate it as Buy, 0 as Hold, and 0 as Sell.
How accurate are MRM stock price projections?
Stock price projections, including those for Medirom Healthcare Technologies Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 14, 2026 12:36 PM UTC